DG Maloney

3.9k citations

37 papers · 3.1k indexed · 2 hit papers · h-index 23

Impact in

Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment

Papers in

Transplantation 3
- Renal Transplantation Outcomes and Treatments 3
Pathology and Forensic Medicine 17
- Lymphoma Diagnosis and Treatment 17

Co-authors: Ronald Levy A.J. Grillo-López J. Rosenberg Christine A. White RA Miller Ivor Royston David Bodkin C. Varns
Journals: Blood (12 papers)Bone Marrow Transplantation (5 papers)The Journal of Immunology (3 papers)Journal of Clinical Oncology (3 papers)Journal of Immunotherapy (2 papers)
Partner nations: United States South Africa Germany

In The Last Decade

DG Maloney

37 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. 1997 · 527 citations

Peers

Countries citing papers authored by DG Maloney

Since Specialization

Citations

This map shows the geographic impact of DG Maloney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DG Maloney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DG Maloney more than expected).

Fields of papers citing papers by DG Maloney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DG Maloney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DG Maloney. The network helps show where DG Maloney may publish in the future.

Co-authorship network

The 25 scholars most cited alongside DG Maloney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with DG Maloney Line = papers co-authored together DG Maloney links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Histone marks identify novel transcription factors that parse CAR-T subset-of-origin, clinical potential and expansion Nature Communications ·G Teuber, Ye Zheng, Janaki Purushe, B. Wittann, Jay F. Sarthy, Derek H. Janssens, Alyssa Sheih, Erik L. Kimble, D. Kirchmeier, Tinh-Doan Phi, Jordan Gauthier, Alexandre V. Hirayama, Stanley R. Riddell, Qian Wu, Raphaël Gottardo, DG Maloney, Milani Luca, Steven Henikoff, Cameron J. Turtle	2024	4
2	Abstract P2-09-13: A phase I study of adoptive immunotherapy for ROR1+ advanced triple negative breast cancer (TNBC) with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR) Cancer Research ·Cevallos Leythong, Siow Ming Lee, Cameron J. Turtle, Christoph Berger, G. Quilligan, Shivani Srivastava, D. Schüler, Natalia Puentes, Ted Gooley, Erin Mullane, CN Chaney, Christoph Rader, P.A.F. Gérard, Raphaël Gottardo, DG Maloney, SR Riddell	2019	24
3	A randomized study of melphalan 200 mg/m2 vs 280 mg/m2 as a preparative regimen for patients with multiple myeloma undergoing auto-SCT Bone Marrow Transplantation ·Jack W. Singer, Pamela S. Becker, Ted Gooley, Thomas R. Chauncey, DG Maloney, Ajay K. Gopal, Yang Zhai, Oliver W. Press, Michael Lill, Ján Karaba, Robert Vescio, Leona Holmberg, G. L. Phillips	2015	22
4	A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation Haematologica ·Brian Kornblit, DG Maloney, Barry E. Storer, Michael B. Maris, Lars L. Vindeløv, Parameswaran Hari, Amelia Langston, Michael A. Pulsipher, Wolfgang Bethge, Thomas R. Chauncey, Thoralf Lange, Finn Bo Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, R Storb, Brenda M. Sandmaier	2014	28
5	Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome Bone Marrow Transplantation ·Mary Jo Lechowicz, Hillard M. Lazarus, Joaquim Carreras, Ginna G. Laport, Corey Cutler, Peter H. Wiernik, Gregory A. Hale, Dipnarine Maharaj, Robert Peter Gale, Philip A. Rowlings, César O. Freytes, Alan M. Miller, Julie M. Vose, Richard T. Maziarz, Silvia Montoto, DG Maloney, Parameswaran Hari	2014	64
6	Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center Bone Marrow Transplantation ·Jack W. Singer, Hekuran Alija, Barry E. Storer, T Chauncey, Leona Holmberg, Pamela S. Becker, Brenda M. Sandmaier, Rainer Storb, DG Maloney	2012	20
7	Tumour lysis syndrome: an unusual presentation Anaesthesia ·冷无霜, DG Maloney, C. G. Roland	2010	5
8	Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML Leukemia ·Fábio R. Kerbauy, Rainer Storb, Ute Hegenbart, Ted Gooley, Judith A. Shizuru, Haifa Kathrin Al‐Ali, Jerald P. Radich, DG Maloney, E.D. Agura, Benedetto Bruno, Elliot Epner, Thomas R. Chauncey, Karl G. Blume, Dietger Niederwieser, Brenda M. Sandmaier	2005	37
9	HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL). Blood ·Lalita Norasetthada, Michael B. Maris, Brenda M. Sandmaier, Ted Gooley, Stephen J. Forman, Edward Agura, Richard T. Maziarz, Judith A. Shizuru, D Niederwieser, Rainer Storb, DG Maloney	2004	3
10	NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN Blood ·Qing-Min Jiang, DG Maloney, Ted Gooley, Ute Hegenbart, Judith A. Shizuru, Firoozeh Sahebi, T Chauncey, E.D. Agura, Bénedicte Bruno, Peter A. McSweeney, Stephen J. Forman, Karl G. Blume, D Niederwieser, 侯仁海	2001	32
11	Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older Bone Marrow Transplantation ·Ajay K. Gopal, Rifky Aryo Wahyu Pratama, Tomer Kimia, DG Maloney, Jack W. Singer, FAMOUS CHIDI CHUKUMA, FR Appelbaum, Oliver W. Press	2001	50
12	Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens Bone Marrow Transplantation ·Francisco Gutiérrez-Delgado, DG Maloney, Oliver W. Press, 秀彦福長, Melis Evcimik, Ιωάννης Βούλγαρης, Heather Hooper, CD Buckner, FR Appelbaum, Jack W. Singer	2001	27
13	IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. Journal of Clinical Oncology ·DG Maloney, A.J. Grillo-López, David Bodkin, Christine A. White, 重史黒田, Ivor Royston, C. Varns, J. Rosenberg, Ronald Levy Hit paper breakdown →	1997	527
14	Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody Blood ·Susan J. Knox, RT Hoppe, DG Maloney, Iris C. Gibbs, LEE SOO YEON, Linda Yang, P. Joanne Cornbleet, Ronald Levy	1996	58
15	Pharmacokinetic analysis of serum concentrations of the chimeric anti-CD20 antibody IDEC-C2B8 in patients with relapsed B cell lymphoma David Bodkin, DG Maloney, James A. Neidhart, Clayton A. White, Hyun-Ou Lee, J. Rosenberg, Ren Bo	1995	3
16	Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma Blood ·DG Maloney, 重史黒田, L.W. Song, Peter Akpanpe, J. Rosenberg, A.J. Grillo-López, Ronald Levy Hit paper breakdown →	1994	604
17	MONOCLONAL ANTI-IDIOTYPE ANTIBODY THERAPY OF B-CELL LYMPHOMA: LYMPHOMA REGRESSION CORRELATES WITH THE ABILITY OF THE ANTIBODY TO INDUCE IMMUNOGLOBULIN SIGNAL TRANSDUCTION IN VITRO AND IS NOT PREVENTED BY TUMOR EXPRESSION OF HIGH LEVELS OF BCL-2 PROTEIN Journal of Immunotherapy ·DG Maloney, Wim M.J. Vuist, Ronald Levy	1993	2
18	Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein. The Journal of Immunology ·Mark Kaminski, Kazuo Kitamura, DG Maloney, Ruth Levy	1987	141
19	The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. The Journal of Immunology ·Ada Hatzubai, DG Maloney, Ronald Levy	1981	53
20	In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia Blood ·RA Miller, DG Maloney, OU Ming-xiu, Ronald Levy	1981	187

About DG Maloney

DG Maloney is a scholar working on Transplantation, Pathology and Forensic Medicine, Hematology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), CAR-T cell therapy research (12 papers), Chronic Lymphocytic Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (8 papers), Glycosylation and Glycoproteins Research (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Genetics (882 citations), Pathology and Forensic Medicine (1.3k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations), Immunology (1.2k citations) and Oncology (1.1k citations). DG Maloney has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Ronald Levy, A.J. Grillo-López, J. Rosenberg, Christine A. White, RA Miller, Ivor Royston, David Bodkin, C. Varns, Mark Kaminski and TC Meeker. Their work appears in journals such as Blood, Bone Marrow Transplantation, The Journal of Immunology, Journal of Clinical Oncology and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact